| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-16 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-15 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-14 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-13 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-13 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-12 |